The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold-Reference-Cited by-同舟云学术

The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold

Published:2005-11 Issue:21 Volume:15 Page:4666-4670
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Graczyk Piotr P.,Khan Afzal,Bhatia Gurpreet S.,Palmer Vanessa,Medland Darren,Numata Hirotoshi,Oinuma Hitoshi,Catchick Jacqueline,Dunne Angela,Ellis Moira,Smales Caroline,Whitfield Jonathan,Neame Stephen J.,Shah Bina,Wilton Daniel,Morgan Louise,Patel Toshal,Chung Raymond,Desmond Howard,Staddon James M.,Sato Nobuaki,Inoue Atsushi

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference36 articles.

1. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites

2. Is Apoptosis Key in Alzheimer's Disease?

3. DNA Synthesis and Neuronal Apoptosis Caused by Familial Alzheimer Disease Mutants of the Amyloid Precursor Protein Are Mediated by the p21 Activated Kinase PAK3

4. Induction of neuronal death by ER stress in Alzheimer’s disease

5. Recent advances in Huntingtonʼs disease

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and functionalization of 6,7-dihydro-5H-pyrrolo[1,2-c]imidazole;Synthetic Communications;2023-03-14

2. Synthesis, spectral characterization, protein binding and cytotoxic evaluation of new cobalt(II) and cobalt(III) complexes containing benzimidazolylterpyridine as ligand;Journal of Coordination Chemistry;2022-11-07

3. Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease;Bioorganic Chemistry;2022-11

4. N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors;ACS Medicinal Chemistry Letters;2021-09-21

5. Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors;ACS Medicinal Chemistry Letters;2020-12-13